Fisher & Paykel Healthcare (NZSE:FPH) EV-to-Revenue

: 9.18 (As of Today)

View and export this data going back to 1979. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Fisher & Paykel Healthcare's enterprise value is NZ$15,704 Mil. Fisher & Paykel Healthcare's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was NZ$1,710 Mil. Therefore, Fisher & Paykel Healthcare's EV-to-Revenue for today is 9.18.

The historical rank and industry rank for Fisher & Paykel Healthcare's EV-to-Revenue or its related term are showing as below:

NZSE:FPH' s EV-to-Revenue Range Over the Past 10 Years
Min: 3.12 Med: 7.97 Max: 17.13
Current: 9.18

During the past 13 years, the highest EV-to-Revenue of Fisher & Paykel Healthcare was 17.13. The lowest was 3.12. And the median was 7.97.

NZSE:FPH's EV-to-Revenue is ranked worse than
80.95% of 824 companies
in the Medical Devices & Instruments industry
Industry Median: 3.05 vs NZSE:FPH: 9.18

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-24), Fisher & Paykel Healthcare's stock price is NZ$27.87. Fisher & Paykel Healthcare's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was NZ$2.93. Therefore, Fisher & Paykel Healthcare's PS Ratio for today is 9.50.

Fisher & Paykel Healthcare EV-to-Revenue Historical Data

The historical data trend for Fisher & Paykel Healthcare's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fisher & Paykel Healthcare Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EV-to-Revenue

Get a 7-Day Free Trial

8.35

13.69

9.36

8.45

9.73

Fisher & Paykel Healthcare Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
EV-to-Revenue	Get a 7-Day Free Trial															-	8.45	-	9.73	-

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Fisher & Paykel Healthcare's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fisher & Paykel Healthcare EV-to-Revenue Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Fisher & Paykel Healthcare's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Fisher & Paykel Healthcare's EV-to-Revenue falls into.

Fisher & Paykel Healthcare EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Fisher & Paykel Healthcare's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	15703.701	/	1709.9
	=	9.18

Fisher & Paykel Healthcare's current Enterprise Value is NZ$15,704 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Fisher & Paykel Healthcare's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was NZ$1,710 Mil.

Fisher & Paykel Healthcare (NZSE:FPH) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Fisher & Paykel Healthcare's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	27.87	/	2.933
	=	9.50

Fisher & Paykel Healthcare's share price for today is NZ$27.87.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Sep. 2023 was NZ$2.93.

Fisher & Paykel Healthcare EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Fisher & Paykel Healthcare's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Fisher & Paykel Healthcare (NZSE:FPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fisher & Paykel Healthcare Corp Ltd (NZSE:FPH) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

FSPKF:USA FPLB:Germany FPH:Australia

Address

15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013

Website

https://www.fphcare.com

Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnoea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the U.S., 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.